Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OKUR
HOLDOnKure Therapeutics, Inc. · Healthcare · United States · $166M · Avg Vol: $1M/d
39
StockRankGet insider-trade alerts
Q
31
V
34
M
67
P/E (TTM)
—
ROE
-42.7%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)-3.6%
SMA 50SMA 200
Close
$4.05
RSI (14)
37.8
52W High
$5.38
From 52W High
0.8%
SCORE BREAKDOWN
Quality
31
ROIC
-105.3%5.8
ROE
-42.7%20.8
GP/Assets
—N/A
Op. Margin
0.0%41.3
FCF/Assets
-81.8%2.4
Piotroski
239.0
Int. Cover
-50.0x6.3
D/E Ratio
0.00x91.5
Current Ratio
13.78x91.3
Value
34
P/E (TTM)
—N/A
EV/EBITDA
0.4x25.0
P/FCF
—N/A
P/B
0.9x87.0
P/S
—N/A
Div Yield
—N/A
Momentum
67
52W High %
75%63.3
RS 6M
30%89.7
SMA 50/200
1.18x87.7
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+51%55.0
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$166M
P/E (Forward)
-1.9x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OKUR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc.(you) | $166M | 39 | HOLD |
| DTIL | Precision BioSciences, Inc. | $188M | 40 | HOLD |
| IMUX | Immunic, Inc. | $182M | 38 | HOLD |
| ANTX | AN2 Therapeutics, Inc. | $177M | 35 | SELL |
| VTVT | vTv Therapeutics Inc. | $121M | 39 | HOLD |
| WHWK | Whitehawk Therapeutics, Inc. | $183M | 32 | SELL |
| NKTX | Nkarta, Inc. | $162M | 29 | SELL |
| ACOG | Alpha Cognition Inc. Common Stock | $172M | 28 | SELL |
| NRXP | NRx Pharmaceuticals, Inc. | $161M | 27 | SELL |
| CUE | Cue Biopharma, Inc. | $135M | 30 | SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%